Background

Dr. Philip D. Greenberg, M.D. serves as Head of Program in Immunology at Fred Hutchinson Cancer Research Center. Dr. Greenberg served as Director of the Immunology Program at FHCRC and Co-Director of the Immunology Program for UW Center for AIDS Research since 1988. He joined FHCRC and the Division of Oncology at University of Washington in 1976. He has been a Member of Scientific Advisory Board at Inovio Pharmaceuticals, Inc. since September 2011. Dr. Greenberg serves ... as a Director of Mount Sinai Hospital Montreal. Dr. Greenberg serves as a Member of Scientific Advisory Council of Cancer Research Institute, Inc. Dr. Greenberg serves as a Member of Scientific Advisory Board of Cellerant Therapeutics, Inc. and Immune Design Corp. Dr. Greenberg served as a Member of Scientific Advisory Board of Cerus Corporation since May 2004. He serves as a Member of Scientific Committee at Innate Pharma SA. He serves as a Member of Scientific Advisory Committee at Ludwig Institute for Cancer Research Ltd. He is a Member of Fred Hutchinson Cancer Research Center (FHCRC). He was elected to the American Society of Clinical Investigation, American Association of Physicians, Association of American Physicians, American College of Physicians, and the American Association for the Advancement of Science. He is a Professor of Medicine in Oncology and Immunology at University of Washington. Dr. Greenberg graduated from Washington University with a Degree in Biology. He has MD summa cum laude from State University of New York, Downstate Medical Center in 1971. He completed postdoctoral training at University of California at San Diego.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.